<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>3(12)</volume><submitter>Kumar NP</submitter><journal>JAMA network open</journal><pagination>e2027754</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC7709089</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Association of Plasma Matrix Metalloproteinase and Tissue Inhibitors of Matrix Metalloproteinase Levels With Adverse Treatment Outcomes Among Patients With Pulmonary Tuberculosis.</pubmed_title><pmcid>PMC7709089</pmcid><pubmed_authors>Babu S</pubmed_authors><pubmed_authors>Kumar NP</pubmed_authors><pubmed_authors>Viswanathan V</pubmed_authors><pubmed_authors>Nair D</pubmed_authors><pubmed_authors>Thiruvengadam K</pubmed_authors><pubmed_authors>Sivakumar S</pubmed_authors><pubmed_authors>Banurekha VV</pubmed_authors><pubmed_authors>Moideen K</pubmed_authors><pubmed_authors>Hissar S</pubmed_authors><pubmed_authors>Nancy A</pubmed_authors><pubmed_authors>Kornfeld H</pubmed_authors></additional><is_claimable>false</is_claimable><name>Association of Plasma Matrix Metalloproteinase and Tissue Inhibitors of Matrix Metalloproteinase Levels With Adverse Treatment Outcomes Among Patients With Pulmonary Tuberculosis.</name><description/><dates><release>2020-01-01T00:00:00Z</release><publication>2020 Dec</publication><modification>2025-04-04T19:21:31.69Z</modification><creation>2025-04-04T19:21:31.69Z</creation></dates><accession>S-EPMC7709089</accession><cross_references><pubmed>33258908</pubmed><doi>10.1001/jamanetworkopen.2020.27754</doi></cross_references></HashMap>